Pharmaceuticals as Strategic Assets: Trade, Pricing and Economic Security
This month has seen the launch of TrumpRx – the US Government’s new direct-to-consumer platform with the stated aim of delivering ‘most favoured nation’ drug prices to the US after decades in which Americans paid much more for its medicines than most of the rest of the world. US drug pricing continues to be a […]
Read more